金宏氣體(688106.SH):擬使用超募資金8376.30萬元投資建設北方集成電路二期電子大宗載氣項目
格隆匯9月26日丨金宏氣體(688106.SH)公佈,公司於2024年9月26日召開了第五屆董事會第三十四次會議,審議通過了《關於使用超募資金投資在建項目的議案》,同意公司使用全部剩餘超募資金及其衍生利息、現金管理收益共計8,376.30萬元(截至2024年8月31日超募資金金額,具體金額以轉出時實際金額為準)投資建設北方集成電路二期電子大宗載氣項目。
公司本次使用超募資金投資在建項目,是圍繞公司主營業務展開,滿足公司未來業務發展和市場拓展的需要,進一步增強公司市場競爭力,實現業績的持續增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.